SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and oncology, will present data on cenobamate at the American Epilepsy Society (AES) Annual Meeting, to be held December 1-5, 2023, in Orlando, Florida.
The Stem Cell Therapy market research report works as a backbone for the growth of the healthcare industry. Hence the report has been provided with comprehensive market insights and analysis that offer an advanced perspective of the marketplace. The report provides CAGR values along with its fluctuations for the spe.
Focal or partial seizures are abnormal localized electrical discharges in the brain. They are of two types and exhibit many associated symptoms. Focal seizures can be diagnosed by EEG and brain imaging and treated with drugs and lifestyle changes.